Repatha (evolocumab) is a PCSK9 inhibitor for lowering LDL cholesterol. It currently comes in one form: the SureClick Autoinjector pen. The Pushtronex on-body infusor was discontinued in June 2024 and ...
Yes, Repatha is still available as a medication used to help lower “bad” LDL cholesterol and reduce the risk of serious heart problems. However, while the medication itself is still available, the way ...